| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 786 |
| 1 | ADALIMUMAB | 646 |
| 2 | ASPIRIN | 572 |
| 3 | ASPIRIN 325 MG | 547 |
| 4 | ASPIRIN 81 MG | 547 |
| 5 | ERGOCALCIFEROL | 473 |
| 6 | ETANERCEPT | 431 |
| 7 | METHOTREXATE SODIUM | 412 |
| 8 | OMEPRAZOLE MAGNESIUM | 407 |
| 9 | PREDNISONE | 400 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PSYLLIUM HUSK | 22 | 0.0163 |
| 1 | ERGOCALCIFEROL | 473 | 0.0159 |
| 2 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 34 | 0.0123 |
| 3 | PERFLUTREN | 55 | 0.0096 |
| 4 | INFLIXIMAB-DYYB | 30 | 0.0087 |
| 5 | COLLAGENASE CLOSTRIDIUM HISTOLYTICUM | 36 | 0.0066 |
| 6 | CLINDAMYCIN PHOSPHATE | 35 | 0.0063 |
| 7 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 76 | 0.0062 |
| 8 | EDOXABAN TOSYLATE | 41 | 0.0060 |
| 9 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 25 | 0.0055 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1229 |
| 1 | Corticosteroid [EPC] | 968 |
| 2 | RANK Ligand Inhibitor [EPC] | 786 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 628 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 591 |
| 5 | Benzodiazepine [EPC] | 516 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 474 |
| 7 | Provitamin D2 Compound [EPC] | 473 |
| 8 | Vitamin C [EPC] | 471 |
| 9 | Proton Pump Inhibitor [EPC] | 469 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 24 | 0.0349 |
| 1 | l-Triiodothyronine [EPC] | 1 | 0.0196 |
| 2 | Provitamin D2 Compound [EPC] | 473 | 0.0159 |
| 3 | Lead Chelator [EPC] | 1 | 0.0119 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 21 | 0.0101 |
| 5 | Contrast Agent for Ultrasound Imaging [EPC] | 55 | 0.0094 |
| 6 | Sucrose-specific Enzyme [EPC] | 1 | 0.0055 |
| 7 | PCSK9 Inhibitor [EPC] | 113 | 0.0044 |
| 8 | RANK Ligand Inhibitor [EPC] | 786 | 0.0039 |
| 9 | Interleukin-17A Antagonist [EPC] | 129 | 0.0035 |